A total of 21 Trichosporon spp. isolates from blood over a period of 5 years (January 2009 to December 2013) were included in the study. The most common underlying diseases found were pancreatitis (33.3%) and cancer (33.3%). Trichosporon asahii (80.9%) was the commonest species followed by Trichosporon mycotoxinivorans (14.2%) and Trichosporon faecale (4.7%). On IGS1 region sequencing the most predominant T. asahii type in our region was genotype 1 (16/17 isolates; 94.1%) and one isolate belonged to genotype 4. Following the interpretative breakpoints for Candida albicans according to CLSI guidelines amphotericin B minimum inhibitory concentrations (MICs) were ≤1 μg/ml for 38% of isolates. Fluconazole MICs were ≤4 μg/ml for 33.3% of the isolates. Itraconazole MICs were ≤0.5 μg/ml for 52.3% of the isolates. However, the MICs to posaconazole and voriconazole were ≤0.5 μg/ml for all the isolates. The MICs to caspofungin and micafungin were ≤0.5 μg/ml for only 0.09% of the isolates. This study reemphasizes that IGS1 sequencing is the most reliable technique for accurate identification of Trichosporon spp. and also to identify the newer species like T. mycotoxinivorans, which still remains rare. Surveillance of antifungal susceptibility patterns can provide the local drug resistance data to the clinicians which can further aid better management of patients.
Introduction
Fungemia is a significant problem in critically ill and immunocompromised patients. The incidence of such infections has increased over time. It corresponds with the rising incidence of patients with malignancies, transplantation and prolonged use of immunosuppressant therapy and other medical devices. 1 Even a small delay in fungemia diagnosis can have serious clinical implications in terms of adverse outcome as these infections are associated with high mortality rate 40-70%. 2, 3 Trichosporon spp. is the second major cause of yeast fungemia in onco-hematological patients preceded by Candida spp. In the past 20th century (1902 through 1992) Trichosporon was designated only one species Trichosporon beigelii. But now based on the sequences of internal transcribed spacer regions (ITS), there are more than 50 species defined under this genus, among which 16 are known to cause human infections, which includes T. cutaneum, T. asahii, T. asteroides, T. mucoides, T. inkin, T. jirovecii, T. dermatis, T. faecale, and T. loubieri of which Trichosporon asahii is the most common species causing deep fungal infections and fungemia. 5, 6 In humans, the members of genus Trichosporon are mostly colonizers of the gastrointestinal tract, respiratory tract, oral cavity, skin, and perigenital area. 7 Depending on host factors, at times patients develop endogenous infections. The early intervention of antifungal agents may result in effective management in these infections and decrease in the mortality rate. [8] [9] [10] There are sporadic reports of trichosporonemia available globally. Here we describe the largest case series of trichosporonemia. Phenotypic and genotypic characterization of isolates was done along with their antifungal profiles.
Materials and methods
Twenty-one bloodstream Trichosporon spp. isolates obtained from admitted patients in a tertiary care hospital in New Delhi between January 2009 and December 2013 were included in the study. All the cases were "proven invasive trichosporonosis" according to the EORTC/IFICG and NIAID/MSG definitions.
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The study was approved by ethics committee of the institute. The consent forms for minor participants were obtained by their LAR, that is, legally accepted representatives (e.g., mother, father, or grandparents).
Identification of Trichosporon spp. isolates by conventional methods
Identification of the yeast isolates was done by standard mycological laboratory procedures including morphology on cornmeal-tween 80 (CMA) agar, reduction of dye on triphenyltetrazolium chloride (TTC) medium, urease enzyme production, and sugar assimilation testing with xylose, ribulose, arabinose, galactose, inositol, raffinose, and rhamnose.
Molecular characterization
DNA extraction, amplification, and sequencing DNA was extracted using the Chelex 100 protocol (Sigma, USA). 12 Segments of DNA comprising the ITS region were amplified with primers ITS1 (5 -TCCGTAGGTGAACCTGCGG-3 )  and  ITS4  (5 -TCCTCCGCTTATTGATATGC-3 ) 13 and for the IGS1 region primers 26SF (5 -ATCCTTTGCAGACGACTTGA-3 ), and 5SR (5 -AGCTTGACTTCGCAGATCGG-3 ) were used. 14 Sequencing reactions were done with 4 μl of a sequencing kit (BigDye Terminator cycle sequencing ready reaction; Applied Biosystems), 1 μM of the above mentioned primers, and 3 μl of the PCR product in a final volume of 10 μl. Sequence analysis was performed by comparison of the test nucleotide sequences with the Trichosporon reference nucleotide sequences obtained from the GenBank database (http://www.ncbi.nih.gov/GenBank/).
Phylogenetic analysis
Sequences were aligned using DNA Baser software. Aligned sequences were used for phylogenetic analysis conducted with Mega 4.0 Beta Software (v 4.0 Beta). The neighbourjoining method was used for preparing the phylogenetic tree for ITS region sequences. The unweightedpair group method using average linkages (UPGMA) was used for preparing the phylogenetic tree for genetic variability among T. asahii IGS1 region sequences. Phylogram stability was accessed by bootstrapping with 1000 pseudoreplications.
Antifungal susceptibility testing
Antifungal susceptibility was performed using the broth microdilution assay 
Results
From 2009 to 2013, there were total of 451 cases of yeast fungemia reported in our tertiary care hospital, out of which 21 (4.6%) cases were of trichosporonemia.
Demographic and clinical data
We had obtained clinical information for 18 out of 21 patients with Trichosporon fungemia as three patients had left the hospital against medical advice and hence their hospital records were incomplete. The mean age of the patients presenting with trichosporonemia was 31.21 years ( Table 1 ). The incidence was more in male (71.4%) as compared to females (23.8%). Pancreatitis (33.3%) and haematological malignancy among the cancer patients (33.3%) were the most common underlying diseases. The commonest risk factors exhibited in our patients were mechanical ventilation (61.1%), tracheostomy (50%), and central venous catheter (44.4%). Sepsis by Trichosporon was seen in two patients following road traffic accidents. One patient each had the inflammatory bowel disease and infective endocarditis. Sixteen patients received antifungal therapy during the course of their illness. Amphotericin B was the most common drug administered (10 cases, 55.5%) followed by fluconazole (5 cases, 27.7%). The disease was invariably fatal in 13 cases out of 18 clinically described (72.2%).
Identification of Trichosporon spp. isolates
Phenotypically, the isolates were placed in the genus Trichosporon. The PCR amplification gen0erated fragments of approximately 500 base pair (bp) (ITS) and 700 bp (IGS1). Table 2 shows the results obtained with different identification methodologies.
The sequence similarities between the pairwise aligned ITS and IGS1 regions of different Trichosporon species found in this study are described constructing a dot-plot using only the representative strains of each species (Fig. 1 ). In the first example, 84.4% similarity in ITS sequences between two species T. mycotoxinivorans (KR132612) and T. insectorum (KR132615) corresponds to 38.5% IGS 1 sequence similarity between T. mycotoxinivorans (KR132598) and T. faecale (KR132601). In the second example, 84.6% similarity in ITS sequences between T. asahii (KR132602) and T. mycotoxinivorans (KR132612) corresponds to 38.2% similarity in the IGS1 sequences between the two species (KP676058, KR132598). In the third example, 99.7% similarity in the ITS sequences between the two species T. asahii (KR132602) and T. insectorum (KR132615) corresponds to 76.4% similarity between T. asahii (KP676059) and T. faecale (KR132601). In the fourth example, the ITS and IGS1 sequences of two such T. asahii isolates were included which on IGS1 sequencing based genotypic analysis were found to be genotype1 and 4. The 100% similarity in ITS region for such T. asahii genotype 1 and 4 isolates (KR132603, KR132609) corresponds to 98.8% similarity in their IGS1 region (KP676059, KP676065). In the fifth example, the ITS and IGS1 sequences of two isolates belonging to T. asahii genotype1 were included, and 100% similarity was observed between their ITS and IGS1 sequences both (KR132603, KR132604, KP676059, KP676060). The interspecies sequence similarities were found lesser in IGS1 region.
Phylogenetic analysis
The neighbor-joining tree based on the ITS regions clustered T. insectorum together with the T. asahii sequences, whereas the T. mycotoxinivorans clustered separately (Fig 2) .
The majority of our T. asahii isolates belonged to genotype 1 (16/17 isolates, 94.1%), while 1 isolate belonged to genotype 4 (Fig. 3) . Representative sequences obtained on ITS and IGS1 sequencing for each species were submitted in the GenBank database (http://www.ncbi.nih.gov/GenBank/).
(Genbank Accession Nos.: KR132598-KR132615, KP676058-KP676072)
Antifungal susceptibility testing
In all experiments, the MIC values of quality control strains fell within the established ranges published by CLSI and EUCAST methodologies. Table 3 summarizes the in vitro susceptibility value ranges of all the isolates to the antifungals tested by the two methodologies followed. The high CLSI/EUCAST MIC values to fluconazole were (≥8/>4 μg/ml) in 66.6/100% isolates, to itraconazole (≥1/>0.06 μg/ml) in 47.6/100% isolates, to posaconazole (≥1/>0.06 μg/ml) in 0/38% isolates, to voriconazole (≥1/>0.12 μg/ml) in 0/23.8% isolates, to 
Discussion
There is paucity of data regarding Trichosporon bloodstream infections from India and there is a risk of underdiagnosis as highlighted by previous studies. 3, 4, 18 To the best of our knowledge, this is the largest trichosporonemia data globally for a five-year period. Global data depict that the incidence rate of invasive Trichosporon infections among patients with malignancies is 0.4-0.6%. 18, 19 In this study, the incidence rate for trichosporonemia was determined for the two most common underlying diseases in our patients and was found lower in patients with malignancies 0.02% (1 case per 1000 cancer patients/time) than those with gastrointestinal manifestations 0.04% (2 cases per 1000 patients with gastrointestinal manifestations/time). Most of our patients were adults (66%) and had undergone invasive procedures like tracheostomy (50%) or were on mechanical ventilation (61%), and only 44.4% of patients had a central venous catheter in place at the time of the diagnosis, which is incongruent to the previously published data. These findings highlight the changing patterns of risk factors for invasive Trichosporon infections. 1, 2, 3, 4, 20 A number of new species has emerged during the past decades, making the identification by conventional methods more difficult. 21, 22 Therefore, molecular tools are preferable for correct species identification. There are previous studies which suggest the use of IGS1 region sequencing over ITS for the identification of described species of Trichosporon. 1, 14, 29 Our study also corroborates with the same (Fig. 1) .
Trichosporon asahii has been documented extensively as an agent of invasive fungal infection worldwide and majority of our isolates were also T. asahii (80.9%). 24, 25, 26, 27 Until now, T. mycotoxinivorans has been mainly reported from cystic fibrosis patients causing pneumonia and also presenting as primary cutaneous trichosporonosis, but here we report three cases of bloodstream infections by this species (14.2%). 28, 29, 30, 31, 32, 40 Another unusual fungemia case noted in this study was caused by T. faecale in a five-month-old child.
There are 11 genotypes of T. asahii described by IGS1 sequencing. 14, 29, 33, 34, 35 14, 33, 36 There are still lacunae in data across the globe regarding the prevalence of different genotypes of T. asahii. Before the taxonomic re-evaluation, T. beigelii was considered to be resistant to amphotericin B. With the revised nomenclature, T. asahii is reported more resistant to amphotericin B than the non-asahii species. 1, 5, 22, 33 T.
asahii has been reported to have better susceptibility to triazoles, with only a few studies reporting resistance to fluconazole. 1, 22, 33 Trichosporon mycotoxinivorans has also been reported to show better susceptibility to voriconazole. 40 In this study, T. asahii showed higher MIC values to fluconazole and amphotericin B in comparison to itraconazole, voriconazole and posaconazole. The authors suggest that voriconazole can be drug of choice in this infection as all the isolates showed the lowest MICs to this drug. Trichosporon spp. has been reported resistant to echinocandins, with breakthrough infections in patients treated with caspofungin and micafungin. 27, 37 However, combination drug therapy, caspofungin/micafungin with amphotericin B/triazoles has shown synergistic effect in vitro and in vivo in some studies. 38, 39 Flucytosine resistance in trichosporonosis is also previously reported, but there are some positive reports that suggest combinational usage with amphotericin B. 18, 23, 36 Our results corroborate with others as our T. asahii showed high MICs to echinocandins and flucytosine, making them an inferior choice for therapy. Amphotericin B MICs were also high (> 1μg/ml) for T. mycotoxinivorans and T. faecale. This is the first study from India in which the EU-CAST proposed method has been compared with the CLSI M27-A3 (S4) for Trichosporon spp. (Table 4 ). The agreements between the CLSI and EUCAST results were within +1dilution for the antifungals tested with no significant variations in the interpretation by both methods (Table 4 ). In addition, ICCs obtained were statistically significant (P < .05) indicating good reproducibility and concordance suggesting both the methods are reliable techniques for susceptibility testing of Trichosporon spp. (Table 4) .
The IGS1 sequencing is a better reliable molecular method for the accurate identification of Trichosporon spp. We report the advent of newer species T. mycotoxinivorans in bloodstream infections. This study reports the prevalence of genotype 1 and genotype 4 in T. asahii bloodstream isolates from India. The most common underlying diseases in the patients were pancreatitis and cancer, whereas the most common risk factors were mechanical ventilation and tracheostomy. Most of the isolates showed high MICs to amphotericin B, flucytosine, and echinocandins. Itraconazole showed moderate MICs whereas fluconazole showed higher MIC values to the isolates. The authors propose on the basis of findings (MIC 50 and MIC 90 ) in this study that voriconazole and posaconazole can be considered as better drugs for therapeutic usage.
Further investigations across the world are required to find the clinical correlation between the different genotypes of T. asahii, spectrum of infection caused by newer species and in vitro and in vivo activities to different antifungal drugs for better management and outcome of patients.
